135 related articles for article (PubMed ID: 10354182)
1. Dendritic cells: role in skin diseases and therapeutic applications.
Nestle FO; Burg G
Clin Exp Dermatol; 1999 May; 24(3):204-7. PubMed ID: 10354182
[TBL] [Abstract][Full Text] [Related]
2. [Dermatology 1997: immune intervention making progress].
Burg G
Schweiz Med Wochenschr; 1998 Jan; 128(1-2):18-20. PubMed ID: 9491463
[No Abstract] [Full Text] [Related]
3. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
Delcayre A; Shu H; Le Pecq JB
Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
[TBL] [Abstract][Full Text] [Related]
4. New technologies toward dendritic cell-based cancer immunotherapies.
Matsue H; Morita A; Matsue K; Takashima A
J Dermatol; 1999 Nov; 26(11):757-63. PubMed ID: 10635619
[TBL] [Abstract][Full Text] [Related]
5. Antitumor Effects of DC Vaccine With ALA-PDT-Induced Immunogenic Apoptotic Cells for Skin Squamous Cell Carcinoma in Mice.
Zhang H; Wang P; Wang X; Shi L; Fan Z; Zhang G; Yang D; Bahavar CF; Zhou F; Chen WR; Wang X
Technol Cancer Res Treat; 2018 Jan; 17():1533033818785275. PubMed ID: 30025490
[TBL] [Abstract][Full Text] [Related]
6. Vaccines and melanoma.
Ott PA; Fritsch EF; Wu CJ; Dranoff G
Hematol Oncol Clin North Am; 2014 Jun; 28(3):559-69. PubMed ID: 24880947
[TBL] [Abstract][Full Text] [Related]
7. [The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].
Döbel T; Schäkel K
J Dtsch Dermatol Ges; 2014 Oct; 12(10):874-80. PubMed ID: 25262889
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells and cutaneous T-cell lymphomas.
Ni X; Duvic M
G Ital Dermatol Venereol; 2011 Apr; 146(2):103-13. PubMed ID: 21505396
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.
Schreurs MW; Eggert AA; Punt CJ; Figdor CG; Adema GJ
Crit Rev Oncog; 2000; 11(1):1-17. PubMed ID: 10795625
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell vaccination as a treatment modality for melanoma.
Eubel J; Enk AH
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1631-42. PubMed ID: 19895246
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells as therapeutic vaccines against cancer.
Banchereau J; Palucka AK
Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell vaccination for the treatment of skin cancer.
Nestle FO
Recent Results Cancer Res; 2002; 160():165-9. PubMed ID: 12079211
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells for specific cancer immunotherapy.
Meidenbauer N; Andreesen R; Mackensen A
Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
[TBL] [Abstract][Full Text] [Related]
14. A novel antigen delivery system induces strong humoral and CTL immune responses.
Yang Z; Xu M; Jia Z; Zhang Y; Wang L; Zhang H; Wang J; Song M; Zhao Y; Wu Z; Zhao L; Yin Z; Hong Z
Biomaterials; 2017 Jul; 134():51-63. PubMed ID: 28456076
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant.
Davis ID; Quirk J; Morris L; Seddon L; Tai TY; Whitty G; Cavicchiolo T; Ebert L; Jackson H; Browning J; MacGregor D; Wittke F; Winkels G; Alex R; Miloradovic L; Maraskovsky E; Chen W; Cebon J
Immunotherapy; 2017 Mar; 9(3):249-259. PubMed ID: 28183192
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
17. [Phase II clinical trial of autologous dendritic cell vaccine with immunologic adjuvant in cutaneous melanoma patients].
Baldueva IA; Novik AV; Moiseenko VM; Nekhaeva TL; Danilova AB; Danilov AO; Protsenko SA; Petrova TIu; Uleĭskaia GI; Shchekina LA; Semenova AI; Mikhaĭlichenko TD; Teletaeva GM; Zhabina AS; Volkov NV; Komarov IuI
Vopr Onkol; 2012; 58(2):212-21. PubMed ID: 22774527
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-based immunotherapy of renal cell carcinoma.
Thurnher M; Rieser C; Höltl L; Papesh C; Ramoner R; Bartsch G
Urol Int; 1998; 61(2):67-71. PubMed ID: 10049189
[TBL] [Abstract][Full Text] [Related]
19. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].
Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG
Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974
[TBL] [Abstract][Full Text] [Related]
20. [Dendritic cells--strong candidates for immunotherapy].
Lund-Johansen F; Olweus J
Tidsskr Nor Laegeforen; 1999 Jun; 119(17):2510-4. PubMed ID: 10425906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
